TANFAC Industries Limited held its Board Meeting on November 02, 2026, which commenced at 12:30 p.m. IST and concluded at 05:20 p.m. IST. The Board considered and approved the Unaudited Financial Results for the second quarter and half year ended September 30, 2026.

Financial Performance (Quarter Ended September 30, 2026)

  • Revenue from Operations: ₹23,048.07 lakhs (compared to ₹16,869.03 lakhs in Q2 FY26)
  • Other Income: ₹381.01 lakhs
  • Total Revenue: ₹23,429.08 lakhs
  • Total Expenses: ₹20,992.87 lakhs
  • Profit Before Tax: ₹2,436.21 lakhs
  • Tax Expense: ₹533.42 lakhs (Current Tax: ₹526.30 lakhs, Deferred Tax: ₹7.12 lakhs)
  • Profit for the Period: ₹1,902.79 lakhs
  • Other Comprehensive Income: ₹13.74 lakhs
  • Total Comprehensive Income: ₹1,916.52 lakhs
  • Basic and Diluted EPS: ₹8.93

Financial Performance (Half Year Ended September 30, 2026)

  • Revenue from Operations: ₹41,765.80 lakhs (compared to ₹34,469.30 lakhs in H1 FY26)
  • Other Income: ₹466.11 lakhs
  • Total Revenue: ₹42,231.91 lakhs
  • Total Expenses: ₹37,420.21 lakhs
  • Profit Before Tax: ₹4,811.70 lakhs
  • Tax Expense: ₹1,223.95 lakhs (Current Tax: ₹1,091.39 lakhs, Deferred Tax: ₹132.56 lakhs)
  • Profit for the Period: ₹3,587.75 lakhs
  • Other Comprehensive Income: ₹13.74 lakhs
  • Total Comprehensive Income: ₹3,601.49 lakhs
  • Basic and Diluted EPS: ₹17.35

Balance Sheet Position (as of September 30, 2026)

  • Total Assets: ₹1,00,601.34 lakhs (compared to ₹52,773.61 lakhs as of March 31, 2026)
  • Non-Current Assets: ₹49,772.58 lakhs
  • Current Assets: ₹50,828.76 lakhs
  • Equity Share Capital: ₹1,081.68 lakhs (Face value ₹5 per share)
  • Other Equity: ₹72,595.61 lakhs
  • Total Shareholders' Funds: ₹73,677.29 lakhs
  • Non-Current Liabilities: ₹7,638.67 lakhs
  • Current Liabilities: ₹19,285.38 lakhs

Significant Corporate Developments

  • The Board recommended a final dividend of ₹4.50 per equity share (face value ₹10) for FY 2025-26, approved by shareholders on September 23, 2026, and paid to shareholders.
  • On January 9, 2026, the Board approved setting up a 20,000 MTPA new downstream fluorinated product plant at an estimated cost of ₹49,500 lakhs.
  • The Board approved raising funds up to ₹50,000 lakhs through Qualified Institutional Placement (QIP), with in-principle approval from BSE received on June 23, 2026.
  • The company successfully launched the QIP, and newly issued shares were listed and available for trading from June 30, 2026.
  • As of September 30, 2026, ₹6,780.91 lakhs from QIP proceeds remained in Escrow Account, Fixed Deposits, and Debt-oriented Mutual Funds pending utilization.
  • The Board approved sub-division of equity shares from face value ₹10 to ₹5 per share, effective from March 9, 2026.
  • The Board approved raising funds up to ₹17,348.73 lakhs via private placement, later reduced to ₹9,841 lakhs.
  • The company allotted 4,24,847 equity shares of ₹5 each at ₹2,341 per share (including premium of ₹2,336) through preferential allotment.
  • As of September 30, 2026, ₹7,555.15 lakhs from preferential issue proceeds remained unutilized.

Operational Highlights

  • The company operates in a single segment: Chemicals in India.
  • All comparative EPS figures have been retrospectively adjusted for the share sub-division effective March 9, 2026.
  • Equity shares issued through QIP and preferential allotment have been considered in weighted-average share computation from their respective allotment dates.